Combination Therapy for Severe GERD in Elderly Patients

Pharmacologic Rationale and Clinical Evidence

The American College of Gastroenterology and the Society of Critical Care Medicine support the use of combination therapy with omeprazole and famotidine for severe GERD, as they have distinct mechanisms of action and do not interfere with each other's metabolic pathways 1
The combination of omeprazole 20mg and famotidine 20mg is pharmacologically sound and can be used safely in elderly patients with severe GERD, without clinically significant drug interactions 1

The Society of Critical Care Medicine recommends low-dose combination therapy: ≤40mg omeprazole daily and ≤40mg famotidine daily for appropriate clinical scenarios, such as severe GERD or stress ulcer prophylaxis 1
For elderly patients with severe GERD, continue omeprazole 20mg once daily in the morning and add famotidine 20mg in the evening for breakthrough symptoms or nocturnal acid control, with reassessment within 12 months if PPI therapy continues long-term 1, 2
Objective confirmation of GERD is necessary, particularly in elderly patients, and should include endoscopy to evaluate for erosive esophagitis, hiatal hernia, and Barrett's esophagus 2

Adding famotidine 20mg to omeprazole 20mg provides a different mechanism of acid suppression and is preferable to simply doubling the PPI dose, keeping both medications at standard doses (≤40mg each) 1
Famotidine does not interfere with clopidogrel's antiplatelet activity, unlike omeprazole, and is a reasonable alternative to PPIs in patients at lower risk for GI bleeding who require clopidogrel 1, 3, 4

Patients with confirmed severe GERD generally require long-term anti-reflux management and should not attempt to wean off therapy, with standardized education on GERD mechanisms, weight management, lifestyle modifications, and the brain-gut axis relationship 2